Dare Bioscience (DARE) Revenue (2014 - 2026)

Dare Bioscience (DARE) has reported Revenue for 8 consecutive years, with $187546.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Revenue rose 985.82% year-over-year to $187546.0; the trailing twelve-month figure through Jun 2026 stood at $1.2 million (up 6835.85% YoY), and the FY2025 full-year result was $1.0 million, up 10429.36% from the prior year.
• Revenue declined to $187546.0 in Q2 2026 per DARE's latest filing, from $1.0 million in the prior quarter.
• Across five years, Revenue topped out at $10.0 million in Q2 2022 and bottomed at -$63647.0 in Q4 2024.
• Historically, Revenue has averaged $1.2 million across 5 years, with a median of $33559.0 in 2024.
• The widest YoY moves for Revenue: up 1708.36% in 2025, down 194.36% in 2025.
• Over 5 years, Revenue stood at $10.0 million in 2022, then plunged by 81.92% to $1.8 million in 2023, then slumped by 103.52% to -$63647.0 in 2024, then jumped by 1708.36% to $1.0 million in 2025, then plunged by 81.68% to $187546.0 in 2026.
• According to Business Quant data, Revenue over the past three periods registered $187546.0, $1.0 million, and $2262.0 for Q2 2026, Q4 2025, and Q3 2025 respectively.